Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
173,37 USD | +0,10% | -1,60% | +11,87% |
13/12 | AbbVie koopt Nimble Therapeutics | MT |
12/12 | Contactlenzenmaker Bausch + Lomb zegt verkoop te overwegen | RE |
Officiële publicaties
3rd quarter results | 30/10 | CO |
SEC Filing 8K | 30/10 | CO |
SEC Filing 10Q-2 | 07/08 | CO |
1st-half-year results | 25/07 | CO |
SEC Filing 8K | 25/07 | CO |
SEC Filing 8K | 03/07 | CO |
SEC Filing 10Q-1 | 03/05 | CO |
1st quarter results | 26/04 | CO |
SEC Filing 8K | 26/04 | CO |
SEC Filing 8K | 03/04 | CO |
Proxy Statments | 18/03 | CO |
SEC Filing 10K | 20/02 | CO |
Annual results | 02/02 | CO |
SEC Filing 8K | 02/02 | CO |
SEC Filing 13G | 25/01 | CO |
SEC Filing 8K | 05/01 | CO |
SEC Filing 10Q-3 | 06/11 | CO |
3rd quarter results | 27-10-23 | CO |
SEC Filing 8K | 27-10-23 | CO |
SEC Filing 8K | 12-10-23 | CO |
SEC Filing 8K | 04-10-23 | CO |
SEC Filing 10Q-2 | 07-08-23 | CO |
1st-half-year results | 27-07-23 | CO |
SEC Filing 8K | 27-07-23 | CO |
SEC Filing 4K | 12-05-23 | CO |
- Beurs
- Aandelen
- Koers ABBV
- Nieuws AbbVie Inc.
- Officiële publicaties